|
Pfizer appoints Rodrigo
Puga as Cluster President
for the Middle East, Russia
& Africa
(DUBAI)
-
Pfizer announces the
appointment of Rodrigo Puga
as Cluster President for the
Middle East, Russia & Africa
(MERA). In this role,
Rodrigo will spearhead
Pfizer’s operations across
the region, leading
strategy, operations, and
performance, while ensuring
patients across the region
have access to breakthrough
innovations.
In his
new position, Rodrigo will
oversee a diverse portfolio
that spans vaccines,
oncology, rare diseases,
internal medicine, and
inflammation and immunology,
while working closely with
partners and stakeholders to
drive sustainable growth and
impact, setting a bold
strategy and delivering on
Pfizer’s goals for MERA.
Commenting on his
appointment, Rodrigo said:
“Over the past three decades
at Pfizer, I’ve had the
privilege of working in many
different markets, each with
its own challenges,
opportunities, and lessons.
These experiences have
shaped how I think about
innovation, collaboration,
and what it truly takes to
deliver meaningful impact
for patients. Taking on the
leadership of MERA is an
exciting new chapter, where
I hope to build on that
learning and expand both my
knowledge and skills in
partnership with our
colleagues, governments, and
stakeholders across the
region. This is a moment to
think boldly about how
Pfizer can accelerate
access, strengthen local
capabilities, and continue
setting new standards in
healthcare for the
communities we serve.”
“What makes MERA so
unique is its extraordinary
diversity. From fast-growing
economies investing heavily
in health infrastructure to
markets pioneering digital
health adoption, this
diversity creates both
complexity and opportunity,
and I believe it’s where
Pfizer can make a real
difference by bringing
global science together with
local insight,” he added.
Rodrigo brings nearly
three decades of experience
with Pfizer, during which he
has built a reputation as a
dynamic, strategic leader
committed to driving
innovation, growth, and
patient-centric solutions.
Most recently, he served as
Senior Vice President and
U.S. Business Lead for
Internal Medicine, where he
oversaw Pfizer’s
cardiovascular, metabolic,
and women’s health
portfolio.
Throughout
his career, Rodrigo has
successfully led full
business turnarounds,
launched new products,
expanded market access, and
driven acquisitions and
integrations. His leadership
roles have spanned the
globe, including Country
President positions in
Mexico, Colombia, and Peru,
as well as senior global
roles such as Global
Marketing Lead for Internal
Medicine and Vice President,
Global Talent Lead.
PRINT
THIS ARTICLE
|
